Optimal secondary prevention medication use in acute myocardial infarction patients with nonobstructive coronary artery disease is modified by management strategy: insights from the TRIUMPH Registry
Reynaria Pitts, Stacie L. Daugherty, Fengming Tang, Philip Jones, P. Michael Ho, Thomas T. Tsai, John Spertus, Thomas M. Maddox
Dive into the research topics of 'Optimal secondary prevention medication use in acute myocardial infarction patients with nonobstructive coronary artery disease is modified by management strategy: insights from the TRIUMPH Registry'. Together they form a unique fingerprint.